• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用免疫系统塑造肿瘤微环境:从免疫代谢到免疫编辑。

Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting.

机构信息

Department of Fundamental Oncology, University of Lausanne, Epalinges, Switzerland.

Ludwig Institute of Cancer Research Lausanne Branch, Epalinges, Switzerland.

出版信息

Clin Exp Immunol. 2019 Aug;197(2):153-160. doi: 10.1111/cei.13293. Epub 2019 Apr 1.

DOI:10.1111/cei.13293
PMID:30873592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6642881/
Abstract

Cancer immunotherapy unleashing the power of host immunity on eliminating cancer cells represents a critical advance in cancer treatment; however, effective anti-tumor responses are largely dampened by the immunosuppressive tumor microenvironment (TME). Emerging studies have revealed that physiological features in the TME, including glucose deprivation, hypoxia and low pH, established by the metabolically dysregulated cancer cells restrict anti-tumor immunity by impeding the metabolic fitness of tumor-infiltrating cytotoxic CD8 T cells and natural killer (NK) cells. Furthermore, infiltrating immunomodulatory cells with different metabolic preferences also facilitate the establishment of the immunosuppressive TME. Therefore, deciphering the metabolic cross-talk between immune cells and cancer cells in the TME and elucidating the impact of this process during tumorigenesis are needed to harness anti-tumor immunity more effectively. Herein, we summarize the immunosuppressive features of TME and how these features impair anti-tumor immunity. Moreover, we postulate how immune cells may be involved in shaping the metabolic features of cancer cells and discuss how we might improve the anti-tumor functions of tumor-specific T cells by rewiring their metabolic regulations.

摘要

癌症免疫疗法利用宿主免疫力消除癌细胞,这是癌症治疗的重大进展;然而,有效的抗肿瘤反应在很大程度上受到免疫抑制性肿瘤微环境(TME)的抑制。新兴的研究表明,肿瘤细胞代谢失调所导致的 TME 中的生理特征,包括葡萄糖剥夺、缺氧和低 pH 值,通过阻碍浸润性细胞毒性 CD8 T 细胞和自然杀伤(NK)细胞的代谢适应性,限制了抗肿瘤免疫。此外,具有不同代谢偏好的浸润性免疫调节细胞也促进了免疫抑制性 TME 的建立。因此,需要破译 TME 中免疫细胞和癌细胞之间的代谢串扰,并阐明这一过程在肿瘤发生过程中的影响,以更有效地利用抗肿瘤免疫。本文总结了 TME 的免疫抑制特征,以及这些特征如何损害抗肿瘤免疫。此外,我们推测免疫细胞如何参与塑造癌细胞的代谢特征,并讨论如何通过重新调整肿瘤特异性 T 细胞的代谢调节来改善其抗肿瘤功能。

相似文献

1
Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting.利用免疫系统塑造肿瘤微环境:从免疫代谢到免疫编辑。
Clin Exp Immunol. 2019 Aug;197(2):153-160. doi: 10.1111/cei.13293. Epub 2019 Apr 1.
2
Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.癌症中调节性T细胞的代谢调控:免疫治疗的机遇
Trends Cancer. 2017 Aug;3(8):583-592. doi: 10.1016/j.trecan.2017.06.005. Epub 2017 Jul 14.
3
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer.利用肿瘤微环境中cDC1与自然杀伤细胞的相互作用来对抗癌症。
Front Immunol. 2021 Feb 19;11:631713. doi: 10.3389/fimmu.2020.631713. eCollection 2020.
4
Functional and metabolic targeting of natural killer cells to solid tumors.自然杀伤细胞对实体瘤的功能和代谢靶向。
Cell Oncol (Dordr). 2020 Aug;43(4):577-600. doi: 10.1007/s13402-020-00523-7. Epub 2020 Jun 2.
5
Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.癌症相关成纤维细胞靶向策略增强基于树突状细胞疫苗的抗肿瘤免疫反应。
Cancer Sci. 2015 Feb;106(2):134-42. doi: 10.1111/cas.12584. Epub 2015 Jan 16.
6
CD8 cytotoxic T lymphocytes in cancer immunotherapy: A review.癌症免疫治疗中的 CD8 细胞毒性 T 淋巴细胞:综述。
J Cell Physiol. 2019 Jun;234(6):8509-8521. doi: 10.1002/jcp.27782. Epub 2018 Nov 22.
7
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.采用 IL-2 细胞因子靶向肿瘤的抗癌疗法:固有、适应性和免疫抑制细胞在抗肿瘤疗效中的贡献。
Front Immunol. 2018 Dec 18;9:2905. doi: 10.3389/fimmu.2018.02905. eCollection 2018.
8
Influence of Innate Immunity on Cancer Cell Stemness.先天免疫对肿瘤干细胞干性的影响。
Int J Mol Sci. 2020 May 9;21(9):3352. doi: 10.3390/ijms21093352.
9
Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.靶向 SLC1A5 和 SLC3A2/SLC7A5 作为增强肿瘤微环境中抗肿瘤免疫的潜在策略。
Front Immunol. 2021 Apr 19;12:624324. doi: 10.3389/fimmu.2021.624324. eCollection 2021.
10
The impact of hypoxia on immune state in cancer.缺氧对癌症免疫状态的影响。
Life Sci. 2021 Dec 1;286:120057. doi: 10.1016/j.lfs.2021.120057. Epub 2021 Oct 16.

引用本文的文献

1
The role of tumor microenvironment and self-organization in cancer progression: Key insights for therapeutic development.肿瘤微环境和自组织在癌症进展中的作用:治疗开发的关键见解。
Bioimpacts. 2024 Dec 7;15:30713. doi: 10.34172/bi.30713. eCollection 2025.
2
Age- and diet-instructed metabolic rewiring of the tumor-immune microenvironment.年龄和饮食指导下的肿瘤免疫微环境代谢重塑。
J Exp Med. 2025 Jun 2;222(6). doi: 10.1084/jem.20241102. Epub 2025 Apr 11.
3
The prognostic value of LAYN in HPV-related head and neck squamous cell carcinoma and its influence on immune cell infiltration.LAYN在人乳头瘤病毒相关头颈部鳞状细胞癌中的预后价值及其对免疫细胞浸润的影响。
Discov Oncol. 2024 Mar 2;15(1):57. doi: 10.1007/s12672-024-00913-5.
4
Immune Features of Tumor Microenvironment: A Genetic Spotlight.肿瘤微环境的免疫特征:基因聚焦
Cell Biochem Biophys. 2024 Mar;82(1):107-118. doi: 10.1007/s12013-023-01192-7. Epub 2023 Oct 23.
5
MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products.MYC 癌基因:天然产物治疗癌症的可用药靶。
Aging Dis. 2024 Apr 1;15(2):640-697. doi: 10.14336/AD.2023.0520.
6
Lymphocyte subset is more suitable than systemic inflammatory response biomarker and immunoglobulin in constructing prognostic nomogram model for advanced gastric cancer.在构建晚期胃癌预后列线图模型方面,淋巴细胞亚群比全身炎症反应生物标志物和免疫球蛋白更合适。
Heliyon. 2023 Mar 20;9(3):e14669. doi: 10.1016/j.heliyon.2023.e14669. eCollection 2023 Mar.
7
An immunometabolism subtyping system identifies S100A9 macrophage as an immune therapeutic target in colorectal cancer based on multiomics analysis.基于多组学分析的免疫代谢亚型系统确定 S100A9 巨噬细胞为结直肠癌的免疫治疗靶点。
Cell Rep Med. 2023 Apr 18;4(4):100987. doi: 10.1016/j.xcrm.2023.100987. Epub 2023 Mar 28.
8
Emerging Trends in Nano-Driven Immunotherapy for Treatment of Cancer.纳米驱动免疫疗法治疗癌症的新趋势
Vaccines (Basel). 2023 Feb 16;11(2):458. doi: 10.3390/vaccines11020458.
9
Cancer immunoediting hypothesis: history, clinical implications and controversies.癌症免疫编辑假说:历史、临床意义及争议
Cent Eur J Immunol. 2022;47(2):168-174. doi: 10.5114/ceji.2022.117376. Epub 2022 Jun 30.
10
A flexible liposomal polymer complex as a platform of specific and regulable immune regulation for individual cancer immunotherapy.一种灵活的脂质体聚合物复合物,作为一种针对个体癌症免疫治疗的特异性和可调节免疫调节的平台。
J Exp Clin Cancer Res. 2023 Jan 23;42(1):29. doi: 10.1186/s13046-023-02601-8.

本文引用的文献

1
Activation of phagocytosis by immune checkpoint blockade.免疫检查点阻断激活吞噬作用。
Front Med. 2018 Aug;12(4):473-480. doi: 10.1007/s11684-018-0657-5. Epub 2018 Jul 30.
2
Targeting Metabolic Cross Talk between Cancer Cells and Cancer-Associated Fibroblasts.靶向肿瘤细胞与肿瘤相关成纤维细胞间的代谢串扰
Adv Exp Med Biol. 2018;1063:167-178. doi: 10.1007/978-3-319-77736-8_12.
3
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors.髓源性抑制细胞阻碍免疫检查点抑制剂的抗癌活性。
Front Immunol. 2018 Jun 11;9:1310. doi: 10.3389/fimmu.2018.01310. eCollection 2018.
4
T Cell Dysfunction in Cancer.肿瘤中的 T 细胞功能障碍。
Cancer Cell. 2018 Apr 9;33(4):547-562. doi: 10.1016/j.ccell.2018.03.012.
5
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy.肿瘤糖酵解增加是对过继性 T 细胞治疗产生免疫抵抗的特征。
Cell Metab. 2018 May 1;27(5):977-987.e4. doi: 10.1016/j.cmet.2018.02.024. Epub 2018 Apr 5.
6
Regulatory T cells: a potential target in cancer immunotherapy.调节性 T 细胞:癌症免疫治疗的一个潜在靶点。
Ann N Y Acad Sci. 2018 Apr;1417(1):104-115. doi: 10.1111/nyas.13625. Epub 2018 Mar 22.
7
Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape.肿瘤微环境中癌细胞内在机制的塑造作用。
Immunity. 2018 Mar 20;48(3):399-416. doi: 10.1016/j.immuni.2018.03.004.
8
Cancer-associated fibroblasts induce antigen-specific deletion of CD8 T Cells to protect tumour cells.癌症相关成纤维细胞诱导CD8⁺ T细胞发生抗原特异性缺失以保护肿瘤细胞。
Nat Commun. 2018 Mar 5;9(1):948. doi: 10.1038/s41467-018-03347-0.
9
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy.从癌症免疫治疗中的免疫检查点阻断中吸取的经验教训。
J Hematol Oncol. 2018 Feb 27;11(1):31. doi: 10.1186/s13045-018-0578-4.
10
The neoepitope landscape in pediatric cancers.儿童癌症中的新抗原图谱。
Genome Med. 2017 Aug 31;9(1):78. doi: 10.1186/s13073-017-0468-3.